Research Article
A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
Table 2
Univariate/multivariate Cox regression analyses.
| Variables | Univariate analysis | Multivariate analysis | HR | 95% CI | value | HR | 95% CI | value |
| Age | | | | | | | ≤ 64/>64 | 2.567 | 0.888-7.419 | 0.082 | 1.543 | 0.514-4.631 | 0.439 | Grade | | | | | | | G1-2/G3 | 1.022 | 0.502-2.077 | 0.953 | 0.979 | 0.479-2.002 | 0.953 | FIGO stage | | | | | | | I-II/III-IV | 0.948 | 0.288-3.124 | 0.931 | 0.764 | 0.219-2.669 | 0.673 | LNM status | | | | | | | Positive/negative | 2.886 | 1.435-5.803 | 0.003 | 2.660 | 1.290-5.489 | 0.008 | Risk score | | | | | | | High/low | 3.186 | 1.513-6.711 | 0.003 | 2.743 | 1.285-5.856 | 0.009 |
|
|
CI: confidence interval; FIGO: Fédération Internationale de Gynécologie et d’Obstétrique; HR: hazard ratio; LNM: lymph node metastasis.
|